Q7Z6E9 (RBBP6_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 106.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: E3 ubiquitin-protein ligase RBBP6 EC=6.3.2.- Alternative name(s): Proliferation potential-related protein Protein P2P-R Retinoblastoma-binding Q protein 1 Short name=RBQ-1 Retinoblastoma-binding protein 6 p53-associated cellular protein of testis | ||||||
| Gene names |
| ||||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||||
| Taxonomic identifier | 9606 [NCBI] | ||||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 1792 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | E3 ubiquitin-protein ligase which promotes ubiquitination of YBX1, leading to its degradation by the proteasome. May play a role as a scaffold protein to promote the assembly of the p53/TP53-MDM2 complex, resulting in increase of MDM2-mediated ubiquitination and degradation of p53/TP53; may function as negative regulator of p53/TP53, leading to both apoptosis and cell growth. |
| Pathway | |
| Subunit structure | Interacts with p53/TP53 and RB1 By similarity. Interacts also with MDM2 and YBX1. Interacts with NEK6. Ref.15 Ref.17 Ref.22 |
| Subcellular location | Nucleus › nucleolus. Chromosome. Cytoplasm › cytoskeleton › centrosome. Note: Colocalizes with mitotic chromosomes. Co-localizes with NEK6 in the centrosome. Ref.10 Ref.12 Ref.22 |
| Tissue specificity | Highly expressed in the placenta and testis. Expressed at lower levels in the brain, heart, kidney, liver and lung. Overexpressed in esophageal cancer. Ref.12 |
| Post-translational modification | Phosphorylated by NEK6. Ref.22 |
| Sequence similarities | Contains 1 CCHC-type zinc finger. Contains 1 DWNN domain. Contains 1 RING-type zinc finger. |
| Sequence caution | The sequence AAG43155.1 differs from that shown. Reason: Intron retention. The sequence AAH63524.1 differs from that shown. Reason: Contaminating sequence. Potential poly-A sequence. The sequence AAL05625.1 differs from that shown. Reason: Frameshift at position 198. The sequence AAL68925.1 differs from that shown. Reason: Intron retention. The sequence BAB15600.1 differs from that shown. Reason: Erroneous initiation. The sequence CAA59445.1 differs from that shown. Reason: Frameshift at positions 198, 1048 and 1098. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| SRSF7 | Q16629 | 3 | EBI-2117026,EBI-398885 |
Alternative products
| This entry describes 4 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q7Z6E9-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q7Z6E9-2) The sequence of this isoform differs from the canonical sequence as follows: 652-685: Missing. | ||||||
| Isoform 3 (identifier: Q7Z6E9-3) The sequence of this isoform differs from the canonical sequence as follows: 102-117: IDDSSASISLAQLTKT → VCKNTISHFFYTLLLPL 118-1792: Missing. | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 4 (identifier: Q7Z6E9-4) The sequence of this isoform differs from the canonical sequence as follows: 431-1270: Missing. | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 1792 | 1792 | E3 ubiquitin-protein ligase RBBP6 | PRO_0000234354 | |||||||||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||||||||
| Domain | 4 – 76 | 73 | DWNN | ||||||||||||||||||||||||||||||||||||||||
| Zinc finger | 159 – 176 | 18 | CCHC-type | ||||||||||||||||||||||||||||||||||||||||
| Zinc finger | 259 – 300 | 42 | RING-type; degenerate | ||||||||||||||||||||||||||||||||||||||||
| Region | 982 – 1139 | 158 | Interaction with RB1 By similarity | ||||||||||||||||||||||||||||||||||||||||
| Region | 1433 – 1544 | 112 | Interaction with p53 By similarity | ||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 244 | 1 | Phosphoserine Ref.13 Ref.23 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 245 | 1 | Phosphoserine Ref.13 Ref.23 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 246 | 1 | Phosphoserine Ref.13 Ref.23 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 247 | 1 | Phosphoserine Ref.13 Ref.23 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 360 | 1 | Phosphoserine Ref.13 Ref.19 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 516 | 1 | Phosphoserine Ref.14 Ref.18 Ref.19 Ref.21 Ref.23 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 770 | 1 | Phosphoserine Ref.13 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 772 | 1 | Phosphoserine Ref.13 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 780 | 1 | Phosphoserine Ref.24 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 861 | 1 | Phosphoserine Ref.13 Ref.23 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 1179 | 1 | Phosphoserine Ref.13 Ref.19 Ref.21 Ref.23 Ref.24 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 1271 | 1 | Phosphothreonine By similarity | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 1277 | 1 | Phosphoserine Ref.21 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 1328 | 1 | Phosphoserine Ref.13 Ref.20 Ref.21 Ref.23 Ref.24 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 1468 | 1 | Phosphothreonine Ref.19 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 1646 | 1 | Phosphoserine Ref.19 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 1648 | 1 | Phosphoserine Ref.19 Ref.21 | ||||||||||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 102 – 117 | 16 | IDDSS…QLTKT → VCKNTISHFFYTLLLPL in isoform 3. | VSP_018281 | |||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 118 – 1792 | 1675 | Missing in isoform 3. | VSP_018282 | |||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 431 – 1270 | 840 | Missing in isoform 4. | VSP_018283 | |||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 652 – 685 | 34 | Missing in isoform 2. | VSP_018284 | |||||||||||||||||||||||||||||||||||||||
| Natural variant | 43 | 1 | D → H. Corresponds to variant rs16973796 [ dbSNP | Ensembl ]. | VAR_051306 | |||||||||||||||||||||||||||||||||||||||
| Natural variant | 555 | 1 | V → A. Corresponds to variant rs16973840 [ dbSNP | Ensembl ]. | VAR_026216 | |||||||||||||||||||||||||||||||||||||||
| Natural variant | 1208 | 1 | K → I. Corresponds to variant rs3743968 [ dbSNP | Ensembl ]. | VAR_051307 | |||||||||||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 223 | 1 | I → T in AAL68925. Ref.5 | ||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 1633 | 1 | D → H in AAL68925. Ref.5 | ||||||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1 – 8 | 8 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 12 – 25 | 14 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 26 – 37 | 12 | |||||||||||||||||||||||||||||||||||||||||
| Turn | 41 – 43 | 3 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 44 – 53 | 10 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 63 – 65 | 3 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 70 – 76 | 7 | |||||||||||||||||||||||||||||||||||||||||
| Turn | 162 – 164 | 3 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 171 – 173 | 3 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 176 – 178 | 3 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 197 – 199 | 3 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 255 – 257 | 3 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 260 – 262 | 3 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 273 – 275 | 3 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 283 – 290 | 8 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 291 – 294 | 4 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 297 – 299 | 3 | |||||||||||||||||||||||||||||||||||||||||
| Turn | 306 – 309 | 4 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 313 – 326 | 14 | |||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Retinoblastoma binding protein 6 (RBBP6), mRNA." Kudo E., Itakura M. Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2). |
| [2] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [3] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-1727 (ISOFORM 4), NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1427-1792 (ISOFORMS 1/2/4). Tissue: Bone and Kidney. |
| [4] | Mao Y.M., Xie Y., Zheng Z.H. Submitted (MAY-1998) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-55 (ISOFORMS 1/2/3/4). Tissue: Fetal brain. |
| [5] | "The cDNA sequence for the human PACT gene." Ma X., Qu X., Sun L., Wu S., He F. Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 117-1792 (ISOFORM 2). Tissue: Spleen. |
| [6] | Camargo A.A., Moreira E.S., Simpson A.J.G. Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 150-1792 (ISOFORM 1). |
| [7] | "cDNA sequence and chromosomal localization of a novel human protein, RBQ-1 (RBBP6), that binds to the retinoblastoma gene product." Sakai Y., Saijo M., Coelho K., Kishino T., Niikawa N., Taya Y. Genomics 30:98-101(1995) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 150-1146 (ISOFORM 1). Tissue: Lung carcinoma. |
| [8] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1165-1792 (ISOFORMS 1/2). Tissue: Hepatoma. |
| [9] | "The full-ORF clone resource of the German cDNA consortium." Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., Wiemann S., Schupp I. BMC Genomics 8:399-399(2007) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1264-1792 (ISOFORMS 1/2). Tissue: Amygdala. |
| [10] | "P2P-R protein localizes to the nucleolus of interphase cells and the periphery of chromosomes in mitotic cells which show maximum P2P-R immunoreactivity." Gao S., Witte M.M., Scott R.E. J. Cell. Physiol. 191:145-154(2002) [PubMed] [Europe PMC] [Abstract] Cited for: SUBCELLULAR LOCATION. |
| [11] | Erratum Gao S., Witte M.M., Scott R.E. J. Cell. Physiol. 192:359-360(2002) |
| [12] | "Proliferation potential-related protein, an ideal esophageal cancer antigen for immunotherapy, identified using complementary DNA microarray analysis." Yoshitake Y., Nakatsura T., Monji M., Senju S., Matsuyoshi H., Tsukamoto H., Hosaka S., Komori H., Fukuma D., Ikuta Y., Katagiri T., Furukawa Y., Ito H., Shinohara M., Nakamura Y., Nishimura Y. Clin. Cancer Res. 10:6437-6448(2004) [PubMed] [Europe PMC] [Abstract] Cited for: SUBCELLULAR LOCATION, TISSUE SPECIFICITY, OVEREXPRESSION IN ESOPHAGEAL CANCER. |
| [13] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-244; SER-245; SER-246; SER-247; SER-360; SER-770; SER-772; SER-861; SER-1179 AND SER-1328, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [14] | "A probability-based approach for high-throughput protein phosphorylation analysis and site localization." Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P. Nat. Biotechnol. 24:1285-1292(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-516, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [15] | "PACT is a negative regulator of p53 and essential for cell growth and embryonic development." Li L., Deng B., Xing G., Teng Y., Tian C., Cheng X., Yin X., Yang J., Gao X., Zhu Y., Sun Q., Zhang L., Yang X., He F. Proc. Natl. Acad. Sci. U.S.A. 104:7951-7956(2007) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH MDM2. |
| [16] | "ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage." Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J. Science 316:1160-1166(2007) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Embryonic kidney. |
| [17] | "RBBP6 interacts with multifunctional protein YB-1 through its RING finger domain, leading to ubiquitination and proteosomal degradation of YB-1." Chibi M., Meyer M., Skepu A., Rees D.J.G., Moolman-Smook J.C., Pugh D.J. J. Mol. Biol. 384:908-916(2008) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH YBX1. |
| [18] | "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis." Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III J. Proteome Res. 7:1346-1351(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-516, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [19] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-360; SER-516; SER-1179; THR-1468; SER-1646 AND SER-1648, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [20] | "Large-scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography." Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D., Zou H., Gu J. Proteomics 8:1346-1361(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1328, MASS SPECTROMETRY. Tissue: Liver. |
| [21] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-516; SER-1179; SER-1277; SER-1328 AND SER-1648, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [22] | "Characterization of hNek6 interactome reveals an important role for its short N-terminal domain and colocalization with proteins at the centrosome." Vaz Meirelles G., Ferreira Lanza D.C., da Silva J.C., Santana Bernachi J., Paes Leme A.F., Kobarg J. J. Proteome Res. 9:6298-6316(2010) [PubMed] [Europe PMC] [Abstract] Cited for: SUBCELLULAR LOCATION, INTERACTION WITH NEK6, PHOSPHORYLATION. |
| [23] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-244; SER-245; SER-246; SER-247; SER-516; SER-861; SER-1179 AND SER-1328, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [24] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-780; SER-1179 AND SER-1328, MASS SPECTROMETRY. |
| [25] | "DWNN, a novel ubiquitin-like domain, implicates RBBP6 in mRNA processing and ubiquitin-like pathways." Pugh D.J.R., Ab E., Faro A., Lutya P.T., Hoffmann E., Rees D.J.G. BMC Struct. Biol. 6:1-1(2006) [PubMed] [Europe PMC] [Abstract] Cited for: STRUCTURE BY NMR OF 1-81. |
| [26] | "Solution structure of the zinc finger CCHC domain and of the RING finger from the human retinoblastoma-binding protein 6 (retinoblastoma-binding Q protein 1, RBQ-1)." RIKEN structural genomics initiative (RSGI) Submitted (APR-2008) to the PDB data bank Cited for: STRUCTURE BY NMR OF 159-309. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AB112074 mRNA. Translation: BAC77636.1. AB112075 mRNA. Translation: BAC77637.1. CH471145 Genomic DNA. Translation: EAW55789.1. BC029352 mRNA. Translation: AAH29352.1. BC063524 mRNA. Translation: AAH63524.1. Sequence problems. BC073938 mRNA. Translation: AAH73938.1. BC101139 mRNA. Translation: AAI01140.1. BC101140 mRNA. Translation: AAI01141.1. BC101141 mRNA. Translation: AAI01142.1. BC101142 mRNA. Translation: AAI01143.1. BC114353 mRNA. Translation: AAI14354.1. BC114354 mRNA. Translation: AAI14355.1. BC118667 mRNA. Translation: AAI18668.1. BC139830 mRNA. Translation: AAI39831.1. AF063596 mRNA. Translation: AAG43155.1. Sequence problems. AY072922 mRNA. Translation: AAL68925.1. Sequence problems. AF352051 mRNA. Translation: AAL05625.1. Frameshift. X85133 mRNA. Translation: CAA59445.1. Frameshift. AK026954 mRNA. Translation: BAB15600.1. Different initiation. AL359564 mRNA. Translation: CAB94869.1. | ||||||||||||||||||||||||||||||
| IPI | IPI00166084. IPI00337315. IPI00376283. IPI00744671. | ||||||||||||||||||||||||||||||
| PIR | A57640. T50609. | ||||||||||||||||||||||||||||||
| RefSeq | NP_008841.2. NM_006910.4. NP_061173.1. NM_018703.3. NP_116015.2. NM_032626.5. | ||||||||||||||||||||||||||||||
| UniGene | Hs.188553. | ||||||||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||||||||
| ProteinModelPortal | Q7Z6E9. | ||||||||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||||||||
| IntAct | Q7Z6E9. 24 interactions. | ||||||||||||||||||||||||||||||
| MINT | MINT-1181085. | ||||||||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||||||||
| PhosphoSite | Q7Z6E9. | ||||||||||||||||||||||||||||||
Polymorphism databases | |||||||||||||||||||||||||||||||
| DMDM | 74762440. | ||||||||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||||||||
| PaxDb | Q7Z6E9. | ||||||||||||||||||||||||||||||
| PRIDE | Q7Z6E9. | ||||||||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||||||||
| DNASU | 5930. | ||||||||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||||||||
| Ensembl | ENST00000319715; ENSP00000317872; ENSG00000122257. ENST00000348022; ENSP00000316291; ENSG00000122257. ENST00000381039; ENSP00000370427; ENSG00000122257. ENST00000452655; ENSP00000390537; ENSG00000122257. | ||||||||||||||||||||||||||||||
| GeneID | 5930. | ||||||||||||||||||||||||||||||
| KEGG | hsa:5930. | ||||||||||||||||||||||||||||||
| UCSC | uc002dmg.3. human. uc002dmh.3. human. uc002dmi.3. human. uc010bxr.3. human. | ||||||||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||||||||
| CTD | 5930. | ||||||||||||||||||||||||||||||
| GeneCards | GC16P024458. | ||||||||||||||||||||||||||||||
| HGNC | HGNC:9889. RBBP6. | ||||||||||||||||||||||||||||||
| HPA | CAB032866. | ||||||||||||||||||||||||||||||
| MIM | 600938. gene. | ||||||||||||||||||||||||||||||
| neXtProt | NX_Q7Z6E9. | ||||||||||||||||||||||||||||||
| PharmGKB | PA34253. | ||||||||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||||||||
| eggNOG | COG5222. | ||||||||||||||||||||||||||||||
| HOVERGEN | HBG061131. | ||||||||||||||||||||||||||||||
| InParanoid | Q7Z6E9. | ||||||||||||||||||||||||||||||
| KO | K10624. | ||||||||||||||||||||||||||||||
| OMA | HSNTIPT. | ||||||||||||||||||||||||||||||
| OrthoDB | EOG44TP8G. | ||||||||||||||||||||||||||||||
| PhylomeDB | Q7Z6E9. | ||||||||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||||||||
| UniPathway | UPA00143. | ||||||||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||||||||
| ArrayExpress | Q7Z6E9. | ||||||||||||||||||||||||||||||
| Bgee | Q7Z6E9. | ||||||||||||||||||||||||||||||
| Genevestigator | Q7Z6E9. | ||||||||||||||||||||||||||||||
| GermOnline | ENSG00000122257. Homo sapiens. | ||||||||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||||||||
| Gene3D | 3.30.40.10. 1 hit. 4.10.60.10. 1 hit. | ||||||||||||||||||||||||||||||
| InterPro | IPR014891. DWNN_domain. IPR001878. Znf_CCHC. IPR001841. Znf_RING. IPR013083. Znf_RING/FYVE/PHD. [Graphical view] | ||||||||||||||||||||||||||||||
| Pfam | PF08783. DWNN. 1 hit. PF00098. zf-CCHC. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||
| SMART | SM00184. RING. 1 hit. SM00343. ZnF_C2HC. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||
| SUPFAM | SSF57756. SSF57756. 1 hit. | ||||||||||||||||||||||||||||||
| PROSITE | PS51282. DWNN. 1 hit. PS50158. ZF_CCHC. 1 hit. PS00518. ZF_RING_1. False negative. PS50089. ZF_RING_2. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||||||||
Other | |||||||||||||||||||||||||||||||
| ChiTaRS | RBBP6. human. | ||||||||||||||||||||||||||||||
| EvolutionaryTrace | Q7Z6E9. | ||||||||||||||||||||||||||||||
| GenomeRNAi | 5930. | ||||||||||||||||||||||||||||||
| NextBio | 23102. | ||||||||||||||||||||||||||||||
| PMAP-CutDB | Q7Z6E9. | ||||||||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||||||||
Entry information
| Entry name | RBBP6_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q7Z6E9 Secondary accession number(s): Q147T5 Q9NPX4 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 16 Human chromosome 16: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PATHWAY comments Index of metabolic and biosynthesis pathways |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
